Distribution of pfmdr1 and pfcrt chloroquine drug resistance alleles in north-western Nigeria

Ruqayyah H Muhammad; Ishaya H Nock; Iliya S Ndams; Jonathan B George; Yusuf Deeni

Distribution of pfmdr1 and pfcrt chloroquine drug resistance alleles in north-western Nigeria

Malariaworld J. 2017 Aug 1:8:15. eCollection 2017.

Authors

Ruqayyah H Muhammad¹, Ishaya H Nock², Iliya S Ndams², Jonathan B George², Yusuf Deeni³

Affiliations

¹ Federal University Dutse, PMB 7156 Jigawa state, Nigeria.
² Ahmadu Bello University, Zaria, Nigeria.
³ University of Abertay, Bell Street Dundee DD1 1HG, UK.

PMID: 34532238
PMCID: PMC8415075

Abstract

Background: In Nigeria, decline in the sensitivity of Plasmodium falciparum to Artemisinin Combination Therapy (ACT) has prompted the unofficial use of chloroquine (CQ) for self-medication. This study was designed to determine the prevalence and distribution of CQ resistant/susceptible alleles of CQ resistance transporter (Pfcrt) and P. falciparum multidrug resistance gene 1 (Pfmdr1) in view of the possible re-introduction of CQ for malaria treatment.

Materials and methods: Four hundred and sixty six (466) P. falciparum positive samples were randomly collected from five states of northwest Nigeria. The samples were amplified using RT- PCR at codon 76 for Pfcrt and codon 86 for Pfmdr1. Data was analysed using chi-square, odds ratios and paired t-tests.

Results: Drug susceptible alleles (N86) were most prevalent in the study population (47.9%; 223/466), followed by the drug resistance alleles 86Y (28.3%; 132/466), followed by the drug susceptible alleles K76 (17.4%; 81/466), the resistant alleles 76T (12.4%; 58/466) and finally the mixed infection mutation K76T (3.6%; 17/466). Differences between the distributions of the Pfmdr1 and Pfcrt alleles were significant (P<0.05). There were significant differences (P<0.05) between N86 and 86Y alleles, but no significant differences between K76 and 76T alleles, including the prevalence of the various alleles across the different age groups.

Conclusion: The results of this study suggest the possibility of (re)introducing CQ for malaria treatment in north-western Nigeria and provide insight in the genetic background of P. falciparum in the study area.